Europe Digital Diabetes Management Market, 2026-2033
The digital diabetes management market in Europe is expected to reach a projected revenue of US$ 8,774.6 million by 2033. A compound annual growth rate of 9.3% is expected of Europe digital diabetes management market from 2026 to 2033.
Abbott Laboratories, Medtronic PLC, Roche Holding AG ADR, Bayer AG, Sanofi SA, DexCom Inc, Insulet Corp, PHC Holdings Corp, B. Braun Medical, Brigade High Income Founders
Other key industry trends
In terms of revenue, Europe region accounted for 30.5% of the global digital diabetes management market in 2025.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 7,382.1 million by 2033.
Increasing prevalence of diabetes and growing awareness about diabetes management & control are among the key factors expected to propel the market over the forecast period. The Russian Federation, Germany, Turkey, Spain, and Italy are the top five countries in the European region with a high incidence of diabetes.
Europe held a significant market share in the global digital diabetes management market, being the second-largest market after North America. This can be primarily attributed to the presence of major players in the region.
New product launches and the implementation of better reimbursement policies are expected to propel the market. In September 2019, Medtronic launched the Envision Pro CGM system, a fully disposable, zero-calibration professional CGM system.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Digital Diabetes Management Market will help companies and investors design strategic landscapes.
Continuous Glucose Monitoring Systems was the largest segment with a revenue share of 43.3% in 2025.
Horizon Databook has segmented the Europe digital diabetes management market based on smart glucose meters, continuous glucose monitoring systems, smart insulin pens, smart insulin pumps/closed loop systems, apps covering the revenue growth of each sub-segment from 2021 to 2033.
Increasing prevalence of diabetes and growing awareness about diabetes management & control are among the key factors expected to propel the market over the forecast period. The Russian Federation, Germany, Turkey, Spain, and Italy are the top five countries in the European region with a high incidence of diabetes.
Europe held a significant market share in the global digital diabetes management market, being the second-largest market after North America. This can be primarily attributed to the presence of major players in the region.
New product launches and the implementation of better reimbursement policies are expected to propel the market. In September 2019, Medtronic launched the Envision Pro CGM system, a fully disposable, zero-calibration professional CGM system.
Europe Digital Diabetes Management Market Product Outlook (Revenue, USD Million , 2021-2033)
Smart Glucose Meters
Continuous Glucose Monitoring Systems
Smart Insulin Pens
Smart Insulin Pumps/Closed Loop Systems
Apps
Europe Digital Diabetes Management Market Type Outlook (Revenue, USD Million , 2021-2033)
Wearable Devices
Hand Held Devices
Reasons to subscribe to digital diabetes management market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of digital diabetes management market databook
Our clientele includes a mix of digital diabetes management market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe digital diabetes management market, including forecasts for subscribers. This continent databook contains high-level insights into Europe digital diabetes management market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Digital Diabetes Management Market, 2021-2033 (US$M)